Bright Rock Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.02M | Hold |
15,500
| – | – | 0.61% | 48 |
|
|
2026
Q1 | $3.48M | Hold |
15,500
| – | – | 0.69% | 50 |
|
|
2025
Q4 | $3.73M | Hold |
15,500
| – | – | 0.73% | 48 |
|
|
2025
Q3 | $4.24M | Hold |
15,500
| – | – | 0.83% | 45 |
|
|
2025
Q2 | $4M | Hold |
15,500
| – | – | 0.81% | 45 |
|
|
2025
Q1 | $3.47M | Hold |
15,500
| – | – | 0.73% | 46 |
|
|
2024
Q4 | $3.54M | Hold |
15,500
| – | – | 0.76% | 42 |
|
|
2024
Q3 | $3.78M | Hold |
15,500
| – | – | 0.76% | 44 |
|
|
2024
Q2 | $2.97M | Hold |
15,500
| – | – | 0.63% | 53 |
|
|
2024
Q1 | $3.07M | Hold |
15,500
| – | – | 0.64% | 53 |
|
|
2023
Q4 | $2.67M | Hold |
15,500
| – | – | 0.6% | 53 |
|
|
2023
Q3 | $2.29M | Hold |
15,500
| – | – | 0.56% | 56 |
|
|
2023
Q2 | $3.39M | Hold |
15,500
| – | – | 0.79% | 42 |
|
|
2023
Q1 | $3.39M | Hold |
15,500
| – | – | 0.85% | 38 |
|
|
2022
Q4 | $3.23M | Hold |
15,500
| – | – | 0.84% | 40 |
|
|
2022
Q3 | $3.38M | Hold |
15,500
| – | – | 0.95% | 40 |
|
|
2022
Q2 | $3.25M | Hold |
15,500
| – | – | 0.88% | 43 |
|
|
2022
Q1 | $3.76M | Hold |
15,500
| – | – | 0.89% | 42 |
|
|
2021
Q4 | $4.04M | Hold |
15,500
| – | – | 0.92% | 43 |
|
|
2021
Q3 | $4.08M | Hold |
15,500
| – | – | 1.02% | 41 |
|
|
2021
Q2 | $3.82M | Hold |
15,500
| – | – | 0.92% | 44 |
|
|
2021
Q1 | $3.01M | Hold |
15,500
| – | – | 0.77% | 47 |
|
|
2020
Q4 | $3.29M | Hold |
15,500
| – | – | 0.9% | 42 |
|
|
2020
Q3 | $2.66M | Sell |
15,500
-1,500
| -9% | -$277K | 0.79% | 48 |
|
|
2020
Q2 | $3.26M | Hold |
17,000
| – | – | 1.02% | 42 |
|
|
2020
Q1 | $2.5M | Sell |
17,000
-3,000
| -15% | -$478K | 0.91% | 45 |
|
|
2019
Q4 | $3.1M | Hold |
20,000
| – | – | 0.91% | 41 |
|
|
2019
Q3 | $2.61M | Hold |
20,000
| – | – | 0.82% | 46 |
|
|
2019
Q2 | $2.44M | Hold |
20,000
| – | – | 0.78% | 44 |
|
|
2019
Q1 | $2.08M | Hold |
20,000
| – | – | 0.7% | 49 |
|
|
2018
Q4 | $2.28M | Hold |
20,000
| – | – | 0.86% | 45 |
|
|
2018
Q3 | $2.31M | Hold |
20,000
| – | – | 0.75% | 45 |
|
|
2018
Q2 | $2.07M | Hold |
20,000
| – | – | 0.71% | 46 |
|
|
2018
Q1 | $1.97M | Hold |
20,000
| – | – | 0.68% | 47 |
|
|
2017
Q4 | $1.69M | Hold |
20,000
| – | – | 0.46% | 69 |
|
|
2017
Q3 | $1.54M | Hold |
20,000
| – | – | 0.45% | 68 |
|
|
2017
Q2 | $1.56M | Hold |
20,000
| – | – | 0.46% | 63 |
|
|
2017
Q1 | $1.44M | Hold |
20,000
| – | – | 0.43% | 71 |
|
|
2016
Q4 | $1.24M | Hold |
20,000
| – | – | 0.38% | 77 |
|
|
2016
Q3 | $1.3M | Hold |
20,000
| – | – | 0.41% | 72 |
|
|
2016
Q2 | $1.26M | Hold |
20,000
| – | – | 0.41% | 66 |
|
|
2016
Q1 | $1.16M | Hold |
20,000
| – | – | 0.39% | 76 |
|
|
2015
Q4 | $1.07M | Sell |
20,000
-13,000
| -39% | -$733K | 0.4% | 77 |
|
|
2015
Q3 | $1.68M | Hold |
33,000
| – | – | 0.67% | 53 |
|
|
2015
Q2 | $1.86M | Buy |
33,000
+10,000
| +43% | +$631K | 0.69% | 49 |
|
|
2015
Q1 | $1.65M | Sell |
23,000
-7,000
| -23% | -$455K | 0.62% | 56 |
|
|
2014
Q4 | $1.68M | Hold |
30,000
| – | – | 0.66% | 52 |
|
|
2014
Q3 | $1.48M | Sell |
30,000
-4,000
| -12% | -$204K | 0.63% | 52 |
|
|
2014
Q2 | $1.72M | Hold |
34,000
| – | – | 0.81% | 39 |
|
|
2014
Q1 | $1.52M | Hold |
34,000
| – | – | 0.77% | 43 |
|
|
2013
Q4 | $1.6M | Buy |
34,000
+3,100
| +10% | +$157K | 0.84% | 42 |
|
|
2013
Q3 | $1.63M | Hold |
30,900
| – | – | 0.92% | 39 |
|
|
2013
Q2 | $1.4M | Buy |
+30,900
| New | +$1.47M | 0.86% | 42 |
|
Other funds holding RMD
AT
DJSG
CIM
AC
MPWT
NAM
CNB
Bright Rock Capital Management's RMD Position: Q2 2026 in Review
Bright Rock Capital Management held its ResMed (RMD) position steady in Q2 2026 at 15,500 shares worth $3.02M. The position accounts for 0.61% of the portfolio, ranked #48.
Bright Rock Capital Management first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.24M in Q3 2025. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Bright Rock Capital Management held 15,500 shares of ResMed worth $3.02M as of Q2 2026.
- Bright Rock Capital Management left its ResMed share count unchanged in Q2 2026.
- ResMed made up 0.61% of Bright Rock Capital Management's portfolio in Q2 2026, its #48 holding.
- Bright Rock Capital Management first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
- Bright Rock Capital Management's ResMed position peaked at $4.24M in Q3 2025.
- 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Bright Rock Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.